{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:32:33Z","timestamp":1781112753513,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Trauma Emerg Surg"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Venous Thromboembolism (VTE) is a common, preventable complication in trauma. Low-molecular-weight heparin (LMWH) is recommended for VTE prophylaxis (VTEp). We investigated whether switching from fixed-dose dalteparin to anti-Xa-guided enoxaparin prophylaxis reduces VTE without increasing the risk of bleeding among hospitalized trauma patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This observational study compared injured patients admitted one year before (pre-P) and after (post-P) implementing a new VTEp protocol. The protocol was introduced as a performance improvement project (subcutaneous enoxaparin 30\u00a0mg twice daily), with dose calibration to peak plasma Anti-Xa level measured after the 3rd dose. The primary outcomes were the rate of VTE and bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After protocol implementation (post-P), 305 patients were compared to 350 pre-protocol patients (pre-P). Anti-Xa levels were measured in 83% of post-P and none in the pre-P. 40% had low levels of anti-Xa, suggesting inadequate prophylaxis, and enoxaparin doses were accordingly increased. 51% attained the desired anti-Xa levels, 9% had higher levels, and LMWH doses were subsequently reduced. VTE incidence after protocol implementation decreased from 4 to 1.3% (OR 0.31; 95% CI 0.1\u20130.9,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03) without increasing the bleeding rate. The time intervals between two consecutive PE events were significantly longer after protocol implementation. Among TBI patients, the rate of VTE was lower. However, it did not reach statistical significance. 75% of patients with VTE had low anti-Xa levels, while 20% of those with bleeding had high anti-Xa levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among adult patients in the trauma ICU, compared to a fixed dose dalteparin, enoxaparin prophylaxis with dose calibration according to peak anti-Xa levels was associated with lower VTE rates without increasing the risk of bleeding. About 40% of patients who received initial enoxaparin doses of 30\u00a0mg twice daily had anti-Xa levels suggestive of inadequate prophylaxis. Calibrating LMWH dosing may improve VTEp following traumatic injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00068-025-02768-z","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:19:08Z","timestamp":1738919948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-xa guided enoxaparin thromboprophylaxis is associated with less thromboembolism than fixed dose dalteparin in trauma patients admitted to intensive care"],"prefix":"10.1007","volume":"51","author":[{"given":"Ahmad","family":"Kloub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbuBaker","family":"Alaieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad","family":"Kanbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha","family":"Abumusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fajer","family":"Alishaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Hinawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naushad Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Asim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Abulkhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2584-953X","authenticated-orcid":false,"given":"Ayman","family":"El-Menyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Al-Thani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Rizoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"5","key":"2768_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.amjsurg.2011.01.012","volume":"201","author":"JA Differding","year":"2011","unstructured":"Differding JA, Underwood SJ, Van PY, et al. Trauma induces a hypercoagulable state that is resistant to hypothermia as measured by thrombelastogram. Am J Surg. 2011;201(5):587\u201391. https:\/\/doi.org\/10.1016\/j.amjsurg.2011.01.012.","journal-title":"Am J Surg"},{"issue":"4","key":"2768_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.surg.2010.07.013","volume":"148","author":"JL Kashuk","year":"2010","unstructured":"Kashuk JL, Moore EE, Johnson JL, et al. Progressive postinjury thrombocytosis is associated with thromboembolic complications. Surgery. 2010;148(4):667\u201374. https:\/\/doi.org\/10.1016\/j.surg.2010.07.013. discussion 674-5.","journal-title":"Surgery"},{"issue":"4","key":"2768_CR3","first-page":"432","volume":"10","author":"M Bahloul","year":"2020","unstructured":"Bahloul M, Dlela M, Bouchaala K, et al. Post-traumatic pulmonary embolism: incidence, physiopathology, risk factors of early occurrence, and impact outcome. A narrative review. Am J Cardiovasc Dis. 2020;10(4):432\u201343.","journal-title":"Am J Cardiovasc Dis"},{"issue":"6 Suppl","key":"2768_CR4","doi-asserted-by":"publisher","first-page":"s381","DOI":"10.1378\/chest.08-0656","volume":"133","author":"WH Geerts","year":"2008","unstructured":"Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest. 2008;133(6 Suppl):s381\u2013453. https:\/\/doi.org\/10.1378\/chest.08-0656.","journal-title":"Chest"},{"issue":"5","key":"2768_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/sla.0000000000005754","volume":"277","author":"A Tran","year":"2023","unstructured":"Tran A, Fernando SM, Gates RS, et al. Efficacy and safety of Anti-xa-guided Versus fixed dosing of low Molecular Weight Heparin for Prevention of venous thromboembolism in Trauma patients: a systematic review and Meta-analysis. Ann Surg. 2023;277(5):734\u201341. https:\/\/doi.org\/10.1097\/sla.0000000000005754.","journal-title":"Ann Surg"},{"issue":"12","key":"2768_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2165\/00003088-200342120-00003","volume":"42","author":"J Fareed","year":"2003","unstructured":"Fareed J, Hoppensteadt D, Walenga J, et al. Pharmacodynamic and pharmacokinetic properties of enoxaparin: implications for clinical practice. Clin Pharmacokinet. 2003;42(12):1043\u201357. https:\/\/doi.org\/10.2165\/00003088-200342120-00003.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"2768_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.36518\/2689-0216.1464","volume":"4","author":"L Sikes","year":"2023","unstructured":"Sikes L, Charles K, Antigua A, et al. Anti-factor Xa Level Monitoring for Enoxaparin Prophylaxis and Treatment in High-Risk patient groups. HCA Healthc J Med. 2023;4(2):105\u20139. https:\/\/doi.org\/10.36518\/2689-0216.1464.","journal-title":"HCA Healthc J Med"},{"issue":"5","key":"2768_CR8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/ta.0000000000002830","volume":"89","author":"EJ Ley","year":"2020","unstructured":"Ley EJ, Brown CVR, Moore EE, et al. Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association critical decisions algorithm. J Trauma Acute care Surg. 2020;89(5):971\u201381. https:\/\/doi.org\/10.1097\/ta.0000000000002830.","journal-title":"J Trauma Acute care Surg"},{"issue":"3","key":"2768_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/ta.0000000000003475","volume":"92","author":"BK Yorkgitis","year":"2022","unstructured":"Yorkgitis BK, Berndtson AE, Cross A, et al. American Association for the Surgery of Trauma\/American College of Surgeons-Committee on Trauma Clinical Protocol for inpatient venous thromboembolism prophylaxis after trauma. J Trauma Acute care Surg. 2022;92(3):597\u2013604. https:\/\/doi.org\/10.1097\/ta.0000000000003475.","journal-title":"J Trauma Acute care Surg"},{"key":"2768_CR10","volume-title":"Quality Health Care: a guide to developing and using indicators","author":"R Lloyd","year":"2004","unstructured":"Lloyd R. Quality Health Care: a guide to developing and using indicators. Jones and Bartlett: Sundbury, MA; 2004."},{"issue":"1","key":"2768_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.chest.2017.08.008","volume":"153","author":"TA Miano","year":"2018","unstructured":"Miano TA, Cuker A, Christie JD, et al. Comparative effectiveness of Enoxaparin vs Dalteparin for Thromboprophylaxis after traumatic Injury. Chest. 2018;153(1):133\u201342. https:\/\/doi.org\/10.1016\/j.chest.2017.08.008.","journal-title":"Chest"},{"issue":"2","key":"2768_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00068-013-0333-z","volume":"40","author":"OT Okoye","year":"2014","unstructured":"Okoye OT, Gelbard R, Inaba K, et al. Dalteparin versus enoxaparin for the prevention of venous thromboembolic events in trauma patients. Eur J Trauma Emerg Surgery: Official Publication Eur Trauma Soc. 2014;40(2):183\u20139. https:\/\/doi.org\/10.1007\/s00068-013-0333-z.","journal-title":"Eur J Trauma Emerg Surgery: Official Publication Eur Trauma Soc"},{"issue":"3","key":"2768_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/mbc.0000000000001281","volume":"35","author":"AL Di Mauro","year":"2024","unstructured":"Di Mauro AL, Austin LJ, Zande J, et al. Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis. Blood Coagulation Fibrinolysis: Int J Haemostasis Thromb. 2024;35(3):101\u20137. https:\/\/doi.org\/10.1097\/mbc.0000000000001281.","journal-title":"Blood Coagulation Fibrinolysis: Int J Haemostasis Thromb"},{"issue":"6","key":"2768_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/ta.0000000000001193","volume":"81","author":"GA Singer","year":"2016","unstructured":"Singer GA, Riggi G, Karcutskie CA, et al. Anti-xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients. J Trauma Acute care Surg. 2016;81(6):1101\u20138. https:\/\/doi.org\/10.1097\/ta.0000000000001193.","journal-title":"J Trauma Acute care Surg"},{"issue":"11","key":"2768_CR15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/jamasurg.2016.1662","volume":"151","author":"A Ko","year":"2016","unstructured":"Ko A, Harada MY, Barmparas G, et al. Association between Enoxaparin Dosage adjusted by Anti-factor Xa Trough Level and clinically evident venous thromboembolism after trauma. JAMA Surg. 2016;151(11):1006\u201313. https:\/\/doi.org\/10.1001\/jamasurg.2016.1662.","journal-title":"JAMA Surg"},{"issue":"2","key":"2768_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamasurg.2017.3787","volume":"153","author":"CA Karcutskie","year":"2018","unstructured":"Karcutskie CA, Dharmaraja A, Patel J, et al. Association of Anti-factor Xa-Guided dosing of Enoxaparin with venous thromboembolism after trauma. JAMA Surg. 2018;153(2):144\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2017.3787.","journal-title":"JAMA Surg"},{"issue":"3","key":"2768_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s00268-020-05849-9","volume":"45","author":"NK Dhillon","year":"2021","unstructured":"Dhillon NK, Barmparas G, Lin TL, et al. A systems-based Approach to reduce deep venous thrombosis and pulmonary embolism in Trauma patients. World J Surg. 2021;45(3):738\u201345. https:\/\/doi.org\/10.1007\/s00268-020-05849-9.","journal-title":"World J Surg"},{"issue":"1","key":"2768_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ta.0000000000003418","volume":"92","author":"RS Gates","year":"2022","unstructured":"Gates RS, Lollar DI, Collier BR, et al. Enoxaparin titrated by anti-xa levels reduces venous thromboembolism in trauma patients. J Trauma Acute care Surg. 2022;92(1):93\u20137. https:\/\/doi.org\/10.1097\/ta.0000000000003418.","journal-title":"J Trauma Acute care Surg"},{"issue":"2","key":"2768_CR19","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/ta.0000000000003580","volume":"93","author":"K Verhoeff","year":"2022","unstructured":"Verhoeff K, Raffael K, Connell M, et al. Relationship between anti-xa level achieved with prophylactic low-molecular weight heparin and venous thromboembolism in trauma patients: a systematic review and meta-analysis. J Trauma Acute care Surg. 2022;93(2):e61\u201370. https:\/\/doi.org\/10.1097\/ta.0000000000003580.","journal-title":"J Trauma Acute care Surg"},{"issue":"2","key":"2768_CR20","doi-asserted-by":"publisher","first-page":"e216356","DOI":"10.1001\/jamasurg.2021.6356","volume":"157","author":"MM Knudson","year":"2022","unstructured":"Knudson MM, Moore EE, Kornblith LZ, et al. Challenging traditional paradigms in Posttraumatic Pulmonary Thromboembolism. JAMA Surg. 2022;157(2):e216356. https:\/\/doi.org\/10.1001\/jamasurg.2021.6356.","journal-title":"JAMA Surg"},{"issue":"3","key":"2768_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa2205973","volume":"388","author":"RV O\u2019Toole","year":"2023","unstructured":"O\u2019Toole RV, Stein DM, O\u2019Hara NN, et al. Aspirin or low-molecular-weight heparin for Thromboprophylaxis after a fracture. N Engl J Med. 2023;388(3):203\u201313. https:\/\/doi.org\/10.1056\/NEJMoa2205973.","journal-title":"N Engl J Med"},{"issue":"4","key":"2768_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/ta.0000000000004226","volume":"96","author":"NN O\u2019Hara","year":"2024","unstructured":"O\u2019Hara NN, O\u2019Toole RV, Frey KP, et al. Risk-stratified thromboprophylaxis effects of aspirin versus low-molecular-weight heparin in orthopedic trauma patients: a secondary analysis of the PREVENT CLOT trial. J Trauma Acute care Surg. 2024;96(4):573\u201382. https:\/\/doi.org\/10.1097\/ta.0000000000004226.","journal-title":"J Trauma Acute care Surg"},{"key":"2768_CR23","doi-asserted-by":"publisher","unstructured":"Bickford A, Majercik S, Bledsoe J et al. Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient. American journal of surgery. 2013;206(6):847\u2013\u200951, discussion 851-2. https:\/\/doi.org\/10.1016\/j.amjsurg.2013.07.020","DOI":"10.1016\/j.amjsurg.2013.07.020"},{"issue":"6","key":"2768_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/000313481508100625","volume":"81","author":"JM Nunez","year":"2015","unstructured":"Nunez JM, Becher RD, Rebo GJ, et al. Prospective evaluation of weight-based prophylactic enoxaparin dosing in critically ill trauma patients: adequacy of AntiXa levels is improved. Am Surg. 2015;81(6):605\u20139.","journal-title":"Am Surg"},{"issue":"1","key":"2768_CR25","doi-asserted-by":"publisher","first-page":"e001230","DOI":"10.1136\/tsaco-2023-001230","volume":"9","author":"S Lombardo","year":"2024","unstructured":"Lombardo S, McCrum M, Knudson MM, et al. Weight-based enoxaparin thromboprophylaxis in young trauma patients: analysis of the CLOTT-1 registry. Trauma Surg Acute care open. 2024;9(1):e001230. https:\/\/doi.org\/10.1136\/tsaco-2023-001230.","journal-title":"Trauma Surg Acute care open"},{"issue":"5","key":"2768_CR26","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1097\/ta.0000000000002438","volume":"87","author":"D Skarupa","year":"2019","unstructured":"Skarupa D, Hanna K, Zeeshan M, et al. Is early chemical thromboprophylaxis in patients with solid organ injury a solid decision? J Trauma Acute care Surg. 2019;87(5):1104\u201312. https:\/\/doi.org\/10.1097\/ta.0000000000002438.","journal-title":"J Trauma Acute care Surg"},{"issue":"11","key":"2768_CR27","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1007\/s00268-019-05096-7","volume":"43","author":"M Schellenberg","year":"2019","unstructured":"Schellenberg M, Inaba K, Biswas S, et al. When is it safe to start VTE Prophylaxis after Blunt Solid Organ Injury? A prospective study from a level I trauma Center. World J Surg. 2019;43(11):2797\u2013803. https:\/\/doi.org\/10.1007\/s00268-019-05096-7.","journal-title":"World J Surg"},{"key":"2768_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jss.2020.08.029","volume":"258","author":"M Hamidi","year":"2021","unstructured":"Hamidi M, Asmar S, Bible L, et al. Early Thromboprophylaxis in Operative spinal trauma does not increase risk of bleeding complications. J Surg Res. 2021;258:119\u201324. https:\/\/doi.org\/10.1016\/j.jss.2020.08.029.","journal-title":"J Surg Res"},{"issue":"5","key":"2768_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/ta.0000000000004007","volume":"95","author":"YT Wu","year":"2023","unstructured":"Wu YT, Chien CY, Matsushima K, et al. Early venous thromboembolism prophylaxis in patients with trauma intracranial hemorrhage: analysis of the prospective multicenter Consortium of leaders in traumatic thromboembolism study. J Trauma Acute care Surg. 2023;95(5):649\u201356. https:\/\/doi.org\/10.1097\/ta.0000000000004007.","journal-title":"J Trauma Acute care Surg"},{"issue":"10","key":"2768_CR30","first-page":"360","volume":"77","author":"EDP van Bergen","year":"2019","unstructured":"van Bergen EDP, Huisman A, Welsing PMJ, et al. Dalteparin and anti-xa: a complex interplay of therapeutic drug monitoring. Neth J Med. 2019;77(10):360\u20135.","journal-title":"Neth J Med"},{"key":"2768_CR31","doi-asserted-by":"publisher","unstructured":"Al-Thani H, El-Menyar A, Khan NA, et al. Trauma quality improvement program: a retrospective analysis from a Middle Eastern National Trauma Center. Healthc (Basel Switzerland). 2023;11(21). https:\/\/doi.org\/10.3390\/healthcare11212865.","DOI":"10.3390\/healthcare11212865"},{"issue":"2","key":"2768_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5847\/wjem.j.1920-8642.2023.016","volume":"14","author":"AF Ramzee","year":"2023","unstructured":"Ramzee AF, El-Menyar A, Asim M, et al. The impact of emergency department length of stay on the outcomes of trauma patients requiring hospitalization: a retrospective observational study. World J Emerg Med. 2023;14(2):96\u2013105. https:\/\/doi.org\/10.5847\/wjem.j.1920-8642.2023.016.","journal-title":"World J Emerg Med"},{"key":"2768_CR33","doi-asserted-by":"publisher","unstructured":"El-Menyar A, Mekkodathil A, Verma V et al. Gender Discrepancy in Patients with Traumatic Brain Injury: A Retrospective Study from a Level 1 Trauma Center. BioMed research international 2022;2022(3147340. https:\/\/doi.org\/10.1155\/2022\/3147340","DOI":"10.1155\/2022\/3147340"}],"container-title":["European Journal of Trauma and Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-025-02768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00068-025-02768-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-025-02768-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:04:24Z","timestamp":1770721464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00068-025-02768-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2768"],"URL":"https:\/\/doi.org\/10.1007\/s00068-025-02768-z","relation":{},"ISSN":["1863-9933","1863-9941"],"issn-type":[{"value":"1863-9933","type":"print"},{"value":"1863-9941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval with a waiver of consent for the study was obtained from the Institutional Review Board of Hamad Medical Corporation, Qatar (MRC#01-23-872) as there was no direct contact with the patients and data were collected anonymously.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}